Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Vows To Be In Top Five In India By 2015; Push Will Come From 13 New Launches In The Next Two Years

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Buoyed by strong performance of its key brands Januvia (sitagliptin) and Gardasil launched last year in India, U.S. drug giant Merck is going full throttle in its ambition to figure in the top five companies in India by 2015
Advertisement

Related Content

A Closer Look At Merck's Commercial Restructuring: What Happened To India?
As Tough Market And Policy Challenges Loom, J&J Names New India Leadership For Pharma Business
Emerging Markets Earnings Roundup: Bayer And Merck (Part 3)
Merck Aims For Deep Dive Into India's Vaccines Market With RotaTeq Launch; May Bring In Many More
Big Brand Fights Come To India As Januvia, Galvus And Onglyza Vie For Market Share
Big Brand Fights Come To India As Januvia, Galvus And Onglyza Vie For Market Share
Merck's Chief Strategy Officer Mervyn Turner Talks To PharmAsia News About Partnerships And Transformational Research Models
Emerging Market Outlook: PharmAsia News Earnings Call Roundup
With AstraZeneca’s Crestor Launch In India, The Fight For Statins Market Is Set To Get Fiercer
With Schering-Plough, Merck Will Have Better Reach And Larger Product Basket In India
Advertisement
UsernamePublicRestriction

Register

SC070885

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel